India’s Auro Realty, the real estate arm of Aurobindo Group which also owns drugmaker Aurobindo Pharma, is planning to raise 20 billion rupees ($225.41 million) through the sale of bonds to fund a key acquisition, two merchant bankers said on Tuesday.